Shows Main Header

ASIO Officers


ASIO Officer


Dr. Jaya Chilakapati is currently a Principal Toxicologist at Boehringer Ingelheim Animal Health; Duluth, Georgia. Dr. Chilakapati is responsible for implementation and reporting laboratory animal safety studies to support development and registration of new products, claim extensions, and inline products. She also represents the Safety Assessment Group on Development Project teams. Dr. Chilakapati was previously employed at Alcon, a Novartis Company, Fort Worth, Texas as a Study Director. Before that, Dr. Chilakapati was a postdoctoral researcher at the US EPA, RTP, North Carolina and worked on arsenic in drinking water. Dr. Chilakapati earned her PhD in Toxicology (2006) from University of Louisiana at Monroe, Louisiana, and is a Diplomate of the American Board of Toxicology (2010 Certification Class). Dr. Chilakapati obtained her Bachelor’s degree in Pharmacy from Rajiv Gandhi University, India. She is an author/co-author of several peer-reviewed publications, book chapters and abstracts. She is also an ad hoc reviewer for toxicology journals.

Dr. Chilakapati has been an active member of Society of Toxicology (SOT) since 2002. She served the Society of Toxicology in various roles since then. As a graduate student, she helped conduct various CE courses at SOT. She regularly serves as a roving reporter at the annual SOT meetings. She was also a member of the Award Nomination Committee of Women in Toxicology specialty section and the Regulatory and Safety Evaluation Specialty Section’s (RSESS) Ad Hoc Committee on Toxicology Publications. Within ASIO, Dr. Chilakapati has served as Secretary-Treasurer for ASIO, helped with judging award applications and initiated the ASIO Awards Nomination Committee. Over the years, she has enjoyed mentoring several junior scientists and graduate students in the field of Toxicology.

ASIO Officer

Vice President

Dr. Saurabh G. Vispute is a board-certified toxicologist currently serving as Principal Scientist in Drug Safety Research and Development at Pfizer, where he contributes to non-clinical safety assessment of small molecules and biologics. Prior to joining Pfizer in 2018, Dr. Vispute served as a Study Director at Charles River Laboratories in Reno, NV since 2016. He is primarily involved in design, conduct, interpretation, and reporting of exploratory, mechanistic, and regulatory toxicology studies in rodent and non-rodent animal models. Dr. Vispute obtained PhD in Pharmacology from St. John’s University, NY and is a registered Pharmacist with a Bachelor’s degree in Pharmacy from Mumbai University.

Dr. Vispute has been a member of several professional societies including Life Member of Indian Pharmaceutical Association (IPA), Full Member of Society of Toxicology (SOT), and American College of Toxicology (ACT). He is recipient of 2009 Best Student Runners up by IPA, 2015 Sheldon Murphy Graduate Student Award from Mechanism Specialty Section of SOT and is a recipient of 2019 ASIO-SOT Young Toxicologist Award, amongst other awards and recognition. In addition, he has served as an ambassador for toxicology outreach efforts supported by SOT’s Domestic and International ToxScholar Grant. He has served as a mentor in a NIH-funded Toxicology Mentoring and Skills Development Training (TOXMSDT) program cohort of 2017–18 and is currently serving as a member of ACT’s Early Career Professionals Outreach committee. He is an author/co-author of several peer-reviewed publications and his research has received awards and recognition from various scientific organizations. In addition, he serves as an ad hoc reviewer for peer reviewed journals and volunteers on scientific abstract screening and award review committees and has served as a Chair of ASIO Newsletter Committee.

ASIO Officer

Vice President-Elect

Ashwini Phadnis-Moghe, PhD is a Study Director and an Immunotoxicology Contributing Scientist at Covance Inc., where she monitors Immunotoxicology studies, provides consultation to clients, coordinates efforts of the study team and is responsible for the interpretation, documentation, and reporting of results in support of preclinical safety studies. Dr. Phadnis-Moghe completed her Bachelors’ and Masters’ degree in Microbiology in India and received her dual PhD in Genetics and Integrative Toxicology from Michigan State University in 2014. During her postdoctoral research, she worked on a unique triple knockout rat model and investigated the role of inflammatory receptors in dioxin hepatotoxicity in collaboration with Dow Chemical Co. Since 2017, she also serves as an editorial board member for the journal Toxicology and Applied Pharmacology.

Dr. Phadnis-Moghe has been an active member of SOT since 2010; having consistently served the Society in various roles including as the Councilor for ASIO (2018–2020), the Postdoctoral representative for the Immunotoxicology Specialty Section (2014–2015), the Postdoctoral representative for the Career Resource and Development Committee and the Food Safety Specialty Section (2016–2017). She was also the Chair and co-Chair for the Immunotoxicology Communications committee for 5 years (2010–2014). Dr. Phadnis-Moghe initiated the Immunotoxicology Networking/Mentoring event for students and postdocs, which has been successfully implemented at the SOT annual meetings since 2015. Within ASIO, Dr. Phadnis-Moghe has helped with judging awards for 2 years and co-hosted the reception in 2017. While serving as a Councilor, she helped draft a best practices document and led the organization of a successful career-development webinar in early 2020. Dr. Phadnis-Moghe has presented over 20 conference abstracts, published 12 peer-reviewed journal articles and has been a recipient of a number of awards at SOT (through ASIO, Immunotoxicology specialty section and Michigan Chapter of SOT) and the HESI Future Leaders Travel award. She is actively involved in scientific outreach activities; examples include serving as a panelist at the NIH Center for Cancer Research career forum, Chair of the scientific outreach subgroup within the Immunosafety Technical committee at HESI, lecturing on drug development and toxicology at Cornell University (since 2017) as well as at undergraduate institutions in Mumbai, India. Dr. Phadnis-Moghe would like to further ASIO’s mission by expanding outreach activities for the career development of toxicologists in India and establishing a long-term channel of communication between toxicologists in India and in the US.

ASIO Officer


Pankajini Mallick is a PhD in Pharmaceutical Sciences with strong passion and enthusiasm for supporting cutting-edge pharmaceutical research. Dr. Mallick’s scientific endeavors have focused on advancing drug metabolism and pharmacokinetics with a focus on biokinetics, toxicology and physiologically based computational modeling and simulation to assess the efficacy and safety of chemicals and drugs. She is currently a Principal Scientist within Preclinical Development at Neurocrine Bioscience and is a subject matter expert when it comes to pharmacokinetics and mathematical modeling across a variety of functionalities within drug discovery and development. Dr. Mallick received her PhD in Pharmaceutical Sciences from University of Houston (Texas), where she researched on the role of innate immune system in regulation of drug metabolism and its implication on drug-drug interaction. After graduation, She joined as a postdoctoral fellow at ScitoVation (ICSS division of The Hamner Institutes for Health Sciences) and then transitioned into the role of Scientist III, where she focused on development and application of PBPK modeling and In vitro to In vivo Extrapolation (IVIVE) in chemical risk assessment. She possesses a significant track record of publications in leading journals and has authored 11 peer-reviewed articles, 4 reviews and one book chapter in toxicology, computational modeling and drug metabolism. She has served as ASIO SOT Graduate Student and Post-doctoral Representative and have volunteered as organizer for various ASIO activities at annual reception including mentoring and networking program. As ASIO Newsletter Chair, she has markedly contributed to creating new content and columns to enhance readability and member engagement, including introduction of “Know Your Fellow Scientist” section. Dr. Mallick has also served SOT in other multiple leadership roles: NorCal SOT post-doctoral Representative, Career Resource and Development (CRAD) and Postdoctoral Assembly (PDA) Post-doctoral Representative, Drug discovery and toxicology specialty section (DDTSS) Graduate Student and Postdoctoral Representative, and Councilor.

ASIO Officer

Past President

Dr. Vijaykumar P. Kale is currently working as a Project Toxicologist at Amgen Inc, South San Francisco. Prior to Amgen, Vijay worked as a Study Director at Battelle Memorial Institute, Ohio, and as a Study Director and Veterinary Clinical Pathologist at Zydus Research Center, Ahmedabad, India. He has more than 10 years of experience in drug discovery toxicology. Vijay is certified by American Board of Toxicology (DABT) and EUROTOX (ERT). Vijay pursued Veterinary Medicine degree (BVSc & AH) from Bombay Veterinary College, masters in Veterinary Pathology (MVSc) from S.D. Agricultural University, India, and PhD in Molecular Toxicology from Penn State University, PA, USA. He has authored/co-authored more than 15 papers, several abstracts/posters and delivered oral presentations. He has served as a Student Representative on Biotechnology Specialty Section of SOT, co-editor of newsletters published by BTSS and ASIO-SOT, and councilor on ASIO-SOT. He was a member of Professional Development committee of Graduate Student Leadership Committee (GSLC-SOT). He was also actively involved in graduate student leadership at Pennsylvania State University. Vijay was the founding Vice President of Association of Indians at Hershey at Penn State College of Medicine, Hershey. He has been actively involved in formal-informal mentoring activities through SOT and outside SOT.

ASIO Officer

Senior Councilor

Dr. Adhithiya Charli is a Study Director, at Charles River Laboratories (Horsham, PA). As a Study Director, he conducts pre-clinical safety assessment testing per regulatory and GLP standards in the fields of Development and Reproductive Toxicology (DART), Phototoxicology and Cell/Gene Therapy. He received his doctorate in Toxicology from Iowa State University (Ames, IA) in 2018. After his doctoral graduation, he further went on to work as a postdoctoral research associate at Iowa State University in the College of Veterinary Medicine (2018–2019).

Dr. Charli has a number of scientific and review article publications in high impact peer reviewed journals and has also co-authored several book chapters. Adding on, he has presented his research in many scientific conferences and his research works has been recognized through a number of commendable awards including best posters awards instituted by the ASIO at SOT annual meeting. He is also the proud recipient of the Russ and Lora Talbot Research Graduate Scholarship by College of Veterinary Medicine and Graduate Research Excellence Award by Graduate College at Iowa State University. Adhithiya also serves as a manuscript reviewer for the Toxicological Sciences. Dr. Charli has been a member of the SOT since 2013 (started as a graduate student member) and has served as the graduate student officer for the Biotechnology Specialty Section (2015–2017). He currently holds the Associate Member status at the SOT and ACT.

One a lighter note, Adhithiya is a passionate wildlife, nature and Astro (galaxy) photographer, with some timely captured pictures published in famous photography magazines.

ASIO Officer

Junior Councilor

Hemantkumar D. Chavan, PhD, DABT is Toxicologist in Development Sciences group of Sana Biotechnology, where he provides nonclinical toxicology representation to Cell and Gene Therapy programs across multiple therapeutic areas. Prior to joining Sana, Dr. Chavan served as a Study Director within Drug Safety assessment group at Charles River Laboratories in Reno. Dr. Chavan is a Pharmacy graduate and received his PhD in Toxicology from the University of Kansas (2013) and postdoctoral training from Kansas University Medical center (2013–2017). Dr. Chavan has published more than 20 peer reviewed articles and presented his research at several scientific meetings. Dr. Chavan is a recipient of awards and recognition by various scientific organizations including SOT. He is editorial board member of Drug Metabolism Letters, and Toxicology and Forensic Medicine and serves as an ad hoc reviewer for several peer reviewed journals.

Dr. Chavan is member of Society of Toxicology since 2010. Dr. Chavan is an active volunteer in SOT and actively participating in various scientific sessions of SOT. Dr. Chavan has served as Secretary for Northern California chapter of SOT and graduate student and postdoctoral representative for CS-SOT and Metals Specialty section, respectively. Dr. Chavan has been a member of special interest groups like Cardiovascular Toxicology, Drug Discovery SS, Metals SS, Regulatory and Safety Evaluation SS, and Association of Scientists of Indian Origin. Dr. Chavan has enjoyed serving as an officer for SOT RC/SS and enjoys participating in education, mentoring, and outreach efforts of SOT.

Postdoctoral Representative

Sharavan Ramachandran, PhD is a Postdoctoral Research Scientist at Texas Tech University Health Sciences Center where his research focusses on developing novel cancer therapeutics by drug repurposing. He received his doctorate in Oncology from Texas Tech University Health Sciences Center in 2020. Dr. Ramachandran has served as a volunteer for the ASIO Newsletter 2020, Student Representative for Stem Cells Specialty Section, Session Facilitator in 2 SOT Annual Meetings and is an Alumni Mentor at Nottingham Trent University. When he was a graduate student, he was the proud recipient of 31 awards including the Syngenta Fellowship Grant awarded by SOT. Notably, Dr. Ramachandran spearheaded the development of a graduate student association called Immunotherapeutic and Biotechnology Graduate Student Association (IBGSA) in his university. He has served as the President of IBGSA from 2019–2020. During his tenure, he appointed the IBGSA Executive Committee, drafted the by-laws and teamed with the senior management for instituting the organization and establishing the funds. His team has conducted several recreational and educational events intended to foster collaboration with academic and industrial experts. He has authored 10 peer reviewed publications in high impact journals like Seminars in Cancer Biology, Molecular Therapy-Oncolytics and Seminars in Cell & Developmental. He has been a member of the SOT since 2017 and has served the SOT in the following capacities:

Volunteer for 2020, 2021 ASIO Newsletter.
Student Representative in Stem cells Specialty Section, SOT, 2019.
Session chair in SOT Annual Meeting, 2018, 2019.

Student Representative

Itishree Kaushik is a PhD candidate at TTUHSC, Abilene Campus where her research focuses on the identification of novel drug candidates for the management of pediatric medulloblastoma. Ms. Kaushik completed her Master’s degree from University of Massachusetts, Dartmouth and joined TTUHSC in 2017. She has been a member of SOT since 2018 and has presented her research at SOT 2019 and SOT 2020. She was invited to serve as a session chair for SOT 2020. She is a proud recipient of 17 awards including Syngenta Fellowship Grant awarded by SOT in 2020. Notably, during the academic year 2019–2020, Ms. Kaushik has served as the Vice President of Immunotherapeutics and Biotechnology Graduate Student Association (IBGSA) at TTUHSC and is currently serving as the President of IBGSA. She is also a member of Graduate Council at TTUHSC. At IBGSA, her team has conducted several recreational, educational, and social events. During her term, IBGSA invited several industrial and academic leaders for graduate student’s educational session. Their motive was to expand the social circle of current graduate students and to bring different perspectives of research to the members of the organization. During her journey as a Graduate Student at TTUHSC, Ms. Kaushik has published one scientific paper and six review papers in several high impact factor journals such as Seminars in Cancer Biology and Seminars in Cells and Developmental Biology. Overall, Ms. Kaushik is a hardworking, dedicated and passionate student who thrives to work towards the betterment of society and upcoming scientists.